MS Thinking Tests: Why Some People Say No to Testing

Credibility

Interest

Share:2 min read

Key Takeaway

In a study of 334 people with MS, those with progressive MS, anxiety-related disorders, or no concerns about their thinking were more likely to decline a thinking test.

What They Found

Researchers looked at which people with MS chose not to take a test of thinking skills, such as memory and attention. About 15 in every 100 people in the study declined the test. People with progressive MS, a form in which symptoms tend to worsen over time, were more likely to decline. People with an anxiety-related disorder were also more likely to decline. People who had not reported concerns about their thinking were more likely to decline than those who had.

Who Should Care and Why

If you have MS, this study may help you start a conversation about thinking tests, whether or not you have noticed a problem. A thinking test can be like a checkup for memory and attention, but this study did not test whether taking one improves care. If anxiety makes testing feel hard, you can tell your care team and ask what the test involves. Caregivers can help by listening to concerns rather than assuming why someone says no. Healthcare providers may find it useful to ask about testing in a way that makes room for questions and concerns.

Important Considerations

The study looked at people at one point in time, so it cannot show why they declined testing. It also did not ask whether people who declined had thinking difficulties or what happened to them later. These limits mean the findings can guide a conversation with your care team, but they cannot tell you whether you personally need a test.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Mental Wellness Caregivers Nutrition

Article Topics:

cognitive dysfunctionhealth care accesshealth care seekingmultiple sclerosispatient experienceprogressive

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News